ID

31763

Description

A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers; ODM derived from: https://clinicaltrials.gov/show/NCT01521325

Lien

https://clinicaltrials.gov/show/NCT01521325

Mots-clés

Versions (1)
  1. 26/09/2018 26/09/2018 -
Détendeur de droits

Morphotek

Téléchargé le

26 septembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Mesothelioma NCT01521325

Anglais

Eligibility Mesothelioma NCT01521325

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
female and male subjects > or = 18 years of age
Description

Gender, age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
histologically confirmed mesothelin-expressing cancer
Description

Mesothelin-expressing cancer, histologically confirmed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C4288762
measurable disease that has progressed through prior therapy and that includes a non-hepatic lesion for imaging that is > or = 1.5cm, as defined by recist v1.1 and disease location, at discretion of the physician, or evaluable by clinical symptoms supported by biomarker, radiological or pathological studies conducted within 4 weeks prior to study entry
Description

Prior measurable, progressed disease, non-hepatic lesion; symptoms supported by biomarker, radiological or pathological aspects

Type de données

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1709926
UMLS CUI [2]
C0475440
UMLS CUI [3,1]
C1335499
UMLS CUI [3,2]
C0205269
UMLS CUI [4,1]
C0450429
UMLS CUI [4,2]
C0332300
UMLS CUI [4,3]
C0023884
UMLS CUI [5,1]
C1516986
UMLS CUI [5,2]
C1457887
UMLS CUI [5,3]
C0005516
UMLS CUI [6,1]
C1516986
UMLS CUI [6,2]
C1457887
UMLS CUI [6,3]
C0043299
UMLS CUI [7,1]
C1516986
UMLS CUI [7,2]
C1457887
UMLS CUI [7,3]
C0205469
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known allergy or hypersensitivity to monoclonal antibodies
Description

Allergy/ hypersensitivity to monoclonal antibodies

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003250
known to develop haca
Description

Human Anti-Chimeric Antibody

Type de données

boolean

Alias
UMLS CUI [1]
C4330329
prior treatment with amatuximab
Description

Prior therapy with amatuximab

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C2987611
prior treatment with ss1 (dsfv)pe38 (ss1p)
Description

Prior treatment with ss1 (dsfv)pe38 (ss1p)

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C4330608
UMLS CUI [1,3]
C0004630
UMLS CUI [1,4]
C0598658
prior treatment with another test article within previous 30 days
Description

prior therapy with experimental drug

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0304229
known brain metastasis
Description

Brain metastasis

Type de données

boolean

Alias
UMLS CUI [1]
C0220650
known prosthetic devices that would prohibit imaging ow lesion of interest due to radiographic artifact
Description

Prosthesis which lead to artifact in diagnostic radiological examination

Type de données

boolean

Alias
UMLS CUI [1,1]
C0175649
UMLS CUI [1,2]
C0043299
UMLS CUI [1,3]
C0085089
chemotherapy, biological therapy, radiation therapy or immunotherapy within 3 weeks prior to dosing with amatuximab
Description

Prior chemotherapy, biological therapy, radiation therapy or immunotherapy with amatuximab

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332185
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0332152
UMLS CUI [1,4]
C2987611
UMLS CUI [2,1]
C0332185
UMLS CUI [2,2]
C1531518
UMLS CUI [2,3]
C0332152
UMLS CUI [2,4]
C2987611
UMLS CUI [3,1]
C0332185
UMLS CUI [3,2]
C1522449
UMLS CUI [3,3]
C0332152
UMLS CUI [3,4]
C2987611
UMLS CUI [4,1]
C0332185
UMLS CUI [4,2]
C0021083
UMLS CUI [4,3]
C0332152
UMLS CUI [4,4]
C2987611
Retour au début de la page

Similar models

Eligibility Mesothelioma NCT01521325

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Gender, age
Item
female and male subjects > or = 18 years of age
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Mesothelin-expressing cancer, histologically confirmed
Item
histologically confirmed mesothelin-expressing cancer
boolean
C0006826 (UMLS CUI [1,1])
C4288762 (UMLS CUI [1,2])
Prior measurable, progressed disease, non-hepatic lesion; symptoms supported by biomarker, radiological or pathological aspects
Item
measurable disease that has progressed through prior therapy and that includes a non-hepatic lesion for imaging that is > or = 1.5cm, as defined by recist v1.1 and disease location, at discretion of the physician, or evaluable by clinical symptoms supported by biomarker, radiological or pathological studies conducted within 4 weeks prior to study entry
boolean
C1513041 (UMLS CUI [1,1])
C1709926 (UMLS CUI [1,2])
C0475440 (UMLS CUI [2])
C1335499 (UMLS CUI [3,1])
C0205269 (UMLS CUI [3,2])
C0450429 (UMLS CUI [4,1])
C0332300 (UMLS CUI [4,2])
C0023884 (UMLS CUI [4,3])
C1516986 (UMLS CUI [5,1])
C1457887 (UMLS CUI [5,2])
C0005516 (UMLS CUI [5,3])
C1516986 (UMLS CUI [6,1])
C1457887 (UMLS CUI [6,2])
C0043299 (UMLS CUI [6,3])
C1516986 (UMLS CUI [7,1])
C1457887 (UMLS CUI [7,2])
C0205469 (UMLS CUI [7,3])
Item Group
C0680251 (UMLS CUI)
Allergy/ hypersensitivity to monoclonal antibodies
Item
known allergy or hypersensitivity to monoclonal antibodies
boolean
C0020517 (UMLS CUI [1,1])
C0003250 (UMLS CUI [1,2])
Human Anti-Chimeric Antibody
Item
known to develop haca
boolean
C4330329 (UMLS CUI [1])
Prior therapy with amatuximab
Item
prior treatment with amatuximab
boolean
C1514463 (UMLS CUI [1,1])
C2987611 (UMLS CUI [1,2])
Prior treatment with ss1 (dsfv)pe38 (ss1p)
Item
prior treatment with ss1 (dsfv)pe38 (ss1p)
boolean
C1514463 (UMLS CUI [1,1])
C4330608 (UMLS CUI [1,2])
C0004630 (UMLS CUI [1,3])
C0598658 (UMLS CUI [1,4])
prior therapy with experimental drug
Item
prior treatment with another test article within previous 30 days
boolean
C1514463 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
Brain metastasis
Item
known brain metastasis
boolean
C0220650 (UMLS CUI [1])
Prosthesis which lead to artifact in diagnostic radiological examination
Item
known prosthetic devices that would prohibit imaging ow lesion of interest due to radiographic artifact
boolean
C0175649 (UMLS CUI [1,1])
C0043299 (UMLS CUI [1,2])
C0085089 (UMLS CUI [1,3])
Prior chemotherapy, biological therapy, radiation therapy or immunotherapy with amatuximab
Item
chemotherapy, biological therapy, radiation therapy or immunotherapy within 3 weeks prior to dosing with amatuximab
boolean
C0332185 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0332152 (UMLS CUI [1,3])
C2987611 (UMLS CUI [1,4])
C0332185 (UMLS CUI [2,1])
C1531518 (UMLS CUI [2,2])
C0332152 (UMLS CUI [2,3])
C2987611 (UMLS CUI [2,4])
C0332185 (UMLS CUI [3,1])
C1522449 (UMLS CUI [3,2])
C0332152 (UMLS CUI [3,3])
C2987611 (UMLS CUI [3,4])
C0332185 (UMLS CUI [4,1])
C0021083 (UMLS CUI [4,2])
C0332152 (UMLS CUI [4,3])
C2987611 (UMLS CUI [4,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial